Jefferies Says Buy Neurocrine After Yesterday's 'Unwarranted' Selloff By: TalkMarkets November 15, 2018 at 10:46 AM EST Jefferies analyst Biren Amin tells investors to buy shares of Neurocrine Biosciences after hosting a dinner with management. Read More >> Related Stocks: Neurocrine Bioscienc